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Background
Calpain, intracellular non-lysosomal calcium-dependent
proteinase, is activated by a number of signaling path-
ways that lead to the elevation of intraplatelet calcium
concentrations. Physiological roles of calpain, highly
expressed in platelets, include regulation of platelet
aggregation and adhesion, while excessive activation of
calpain in such pathological disorders as diabetes could
cause changes in platelet functions, resulting in platelet
hyperactivation. Platelets from diabetic patients are also
characterized by resistance to nitric oxide inhibition.
Here we examined if calpain could regulate major
cAMP and cGMP hydrolyzing phosphodiesterases
(PDEs), PDE3A and PDE5, in human platelets.
Results
Elevation of cytosolic calcium in human platelets with
A23187 as well as treatments with thapsigargin, resulted
in increases of catalytic activities of PDE3A and PDE5.
These changes were accomplished by their partial pro-
teolysis. Our data showed that calpain was responsible
for cleavage of PDE3A and PDE5. Calpain, activated by
an increase of cytoplasmic Ca, induced limited proteoly-
sis of cyclic nucleotide PDEs, whereas calpeptin, a cal-
pain inhibitor, was able to block the proteolytic effects
of calpain. PDE3A was very susceptible to the duration
of calpain proteolysis, and prolonged exposure of
PDE3A to the activated calpain led to the generation of
several truncated forms of PDE3A with lower catalytic
activities.
Contrary to PDE3A, calpain cleaved only a part of the
N-terminal domain of PDE5, a region before the PKG-
(serine-102) phosphorylation site. This truncated form
of PDE5 was stable and the only one produced by cal-
pain during its activation. Calpain-activated PDE5 also
showed higher sensitivity towards inhibition by a PDE5
specific inhibitor, sildenafil.
Confocal immunofluorescence analyses of PDE5 loca-
lization in spreading platelets identified PDE5 mostly in
the center, around inner actin rings. Calcium treatments
changed platelets morphology and PDE5 localization,
showing diffuse cellular staining.
Conclusion
Thus our data suggest that Calcium/Calpain induced
cleavage of PDE3A and PDE5 may represent a novel
mechanism of regulation of cyclic nucleotide PDEs in
platelets during development of diabetes and cardiovas-
cular dysfunctions.
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